Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Systematic identification of key functional modules and genes in esophageal cancer

Fig. 6

The expression level, survival analysis, and immune infiltration abundance analysis of CCNB1 in patients with ESCA. a HCMDB analysis of aberrant expression of CCNB1 in ESCA patients. b GEPIA2 analysis of aberrant expression of CCNB1 in ESCA patients. c UALCAN analysis of aberrant expression of CCNB1 in ESCA patients. d UALCAN analysis indicated downregulated promoter methylation level of CCNB1 in ESCA patients. eh The different expression level of CCNB1 based on patients’ gender, age, stages, and histology were explored in ESCA patients using UALCAN website. i K-M curve revealing the prognosis valve of CCNB1 in patients with ESCA. j Correlation analysis between different expressed CCNB1 and immune cell infiltration by utilizing TIMER. k Prognosis of ESCA patients with different immune infiltration abundance

Back to article page